ADVERTISEMENT
(Bloomberg) -- Companies belonging to founders of Lupin Ltd. have transferred shares among themselves amid a 30 percent plunge in the stock, the worst-performer this year on the benchmark S&P BSE Sensex. Lupin Investments Pvt., other group firms and insiders internally transferred or bought $3.1 billion of shares, data for the September quarter compiled by Bloomberg show. India’s second-biggest drugmaker by revenue trades at 18.6 times reported profits, versus 23.8 for the Sensex, with the valuation discount being near the widest since 2009.
ADVERTISEMENT